Response to preoperative therapy may predict survival in pancreatic cancer patients

Cancer of the pancreas - a glandular organ that lies behind the stomach and secretes vital enzymes and hormones - seldom is detected in early stages, making treatment difficult and survival statistics particularly grim. However, new research from Fox Chase Cancer Centre finds that patients with pancreatic adenocarcinoma whose tumours respond most to preoperative chemotherapy and radiation survive four times as long, on average, as those whose tumours respond least...

Read the whole article on

More from